Top Markets
Coin of the day
Immunovant, Inc. Immunovant, Inc.

Immunovant, Inc.

IMVT
Hisse Senetlerindeki Sıralama #2340
Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase,... Immunovant, Inc. is a biopharmaceutical firm in the clinical development phase, dedicated to advancing novel monoclonal antibody therapies for the treatment of various autoimmune conditions. The company's primary focus is batoclimab, a pioneering, fully human monoclonal antibody. This antibody is engineered to specifically target and block the neonatal fragment crystallizable receptor (FcRn), a key mechanism in certain autoimmune diseases. Batoclimab is currently undergoing Phase IIa clinical evaluations for treating both myasthenia gravis and thyroid eye disease. Additionally, it has commenced Phase II clinical studies for patients suffering from warm autoimmune hemolytic anemia. Established in 2018, Immunovant operates from its headquarters in New York, New York, functioning as a subsidiary under the umbrella of Roivant Sciences Ltd.
Hisse Fiyatı
$43.42
Piyasa Değeri
$8.96B
Değişim (1 gün)
0.23%
Değişim (1 yıl)
191.61%
Ülke
US
Ticaret Immunovant, Inc. (IMVT)

Kategori

Immunovant, Inc. (IMVT) için hisse senedi fiyat geçmişi
Gün sonu en yüksek fiyat: $42.51 - 2026-08-01

Gün sonu en düşük fiyat: $9.88 - 2019-06-01
Immunovant, Inc. için hisse fiyatı geçmişi: 2019 - 2026
Yıllık Hisse Fiyatı Performansı
Yıl Performans
2026 (TTM) 8.62%
2025 -7.38%
2024 -34.45%
2023 163.89%
2022 99.44%
2021 -84.02%
2020 273.47%
2019 0.00%
Benzer şirketler veya rakiplerin hisse fiyatı
Şirket Hisse fiyatı Değişim 1yıl% Ülke
$553.23 42.24%
US
$1.02K 50.35%
NL
$157.70 522.09%
US
$122.47 -12.71%
AU
$772.27 8.67%
CH